Skip to main content

Table 2 The overall survival of 170 gastric cancer patients is analyzed after resection

From: The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression

  Univariate analysis (N = 170) Multivariate analysis (N = 170)
  Endpoint status(%)   95% CI  
  Survival Death pvalue Mean Lower Upper pvalue
Gender    0.317 1.425 1.349 1.501 0.320
Male 51 (53.7) 44 (46.3)      
Female 46 (61.3) 29 (38.7)      
Age    0.440 64.797 62.673 66.92 0.718
≤50 years 17 (50.0) 17 (50.0)      
>50 years 78 (57.4) 58 (43.6)      
Tumor Location    0.566 2.494 2.372 2.617 0.991
Proximal 46 (58.2) 33 (41.8)      
Distal 49 (53.8) 42 (46.2)      
Tumor Size (cm)    0.011 4.632 4.208 5.507 0.006
≤5 72 (62.6) 43 (37.4)      
>5 23 (41.8) 32 (58.2)      
Lauren Classification    0.189 2.016 1.875 2.158 0.212
Intestinal 45 (61.6) 28 (38.4)      
Diffuse 50 (51.5) 47 (48.5)      
Tumor Stage    0.000 1.491 1.419 1.563 0.000
Early 65 (68.4) 25 (33.3)      
Advance 30 (31.6) 50 (66.7)      
LN Metastasis    0.000 0.584 0.512 0.656 0.000
No 55 (74.3) 19 (25.7)      
Yes 40 (41.7) 56 (58.3)      
OPN Staining    0.015 2.266 2.125 2.407 0.026
≤50% 52 (65.8) 27 (34.2)      
>50% 43 (47.3) 48 (52.7)      
CD204 Staining    0.034 2.304 2.169 2.439 0.049
≤50% 51 28      
>50% 44 47      
OPN vs. CD204 Staining   0.007 2.678 2.494 2.861 0.001
≤50% vs. ≤50% 36 (76.6) 11 (23.4)      
≤50% vs. >50% 16 (53.3) 14 (46.7)      
>50% vs. ≤50% 15 (50.0) 15 (50.0)      
>50% vs. >50% 28 (44.4) 35 (55.6)      
  1. Statistically significant p values are shown in bold.